PE20060311A1 - Formulacion en aerosol para la inhalacion de beta-agonistas - Google Patents
Formulacion en aerosol para la inhalacion de beta-agonistasInfo
- Publication number
- PE20060311A1 PE20060311A1 PE2005000529A PE2005000529A PE20060311A1 PE 20060311 A1 PE20060311 A1 PE 20060311A1 PE 2005000529 A PE2005000529 A PE 2005000529A PE 2005000529 A PE2005000529 A PE 2005000529A PE 20060311 A1 PE20060311 A1 PE 20060311A1
- Authority
- PE
- Peru
- Prior art keywords
- hydroxy
- dimethyl
- acid
- formulation
- beta
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000443 aerosol Substances 0.000 title abstract 2
- 229940125388 beta agonist Drugs 0.000 title abstract 2
- -1 METANSULPHONATE Chemical compound 0.000 abstract 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 2
- JITFIYFVPMQJOK-UHFFFAOYSA-N 1-(4-fluorophenyl)-2-methylpropan-2-amine Chemical compound CC(C)(N)CC1=CC=C(F)C=C1 JITFIYFVPMQJOK-UHFFFAOYSA-N 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 abstract 1
- LERNTVKEWCAPOY-VOGVJGKGSA-N C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 Chemical compound C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 LERNTVKEWCAPOY-VOGVJGKGSA-N 0.000 abstract 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 abstract 1
- 208000011623 Obstructive Lung disease Diseases 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 238000002663 nebulization Methods 0.000 abstract 1
- 229910017604 nitric acid Inorganic materials 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 1
- 235000002906 tartaric acid Nutrition 0.000 abstract 1
- 239000011975 tartaric acid Substances 0.000 abstract 1
- 229960000257 tiotropium bromide Drugs 0.000 abstract 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
SE REFIERE A UNA FORMULACION FARMACEUTICA EN AEROSOL SIN GAS PROPELENTE QUE COMPRENDE a) COMO PRINCIPIO ACTIVO UN COMPUESTO BETA-AGONISTA DE FORMULA (I), EN DONDE R1 Y R2 SON INDEPENDIENTEMENTE H, ALQUILO(C1-C4), ALCOXI(C1-C4) O HALOGENO; R3 ES R1 O R2, OH, -O-ALQUILEN(C1-C4)-COOH U -O-ALQUILEN(C1-C4)-ALQUILO(C1-C4); X- ES CLORURO, BROMURO, SULFATO, METANSULFONATO, MALEATO, ACETATO, ENTRE OTROS. SON PREFERIDOS: 6-HIDROXI-8-{1-HIDROXI-2,6-DIMETIL-FENIL)-1,1-DIMETIL-ETILAMINO]-ETIL}-4H-BENZO[1,4]OXAZIN-3-ON-METANOSULFONATO, SAL POR ADICION DE ACIDO DE 8-{2-[2-(4-FLUORO-FENIL)-1,1-DIMETIL-ETILAMINO}-1-HIDROXI-ETIL}-6*-HIDROXI-4H-BENZO[1,4}OXAZIN-3-ONA, ENTRE OTROS; b) AL MENOS UN ACIDO INORGANICO TAL COMO ACIDO CLORHIDRICO, BROMHIDRICO, NITRICO, ENTRE OTROS O UN ACIDO ORGANICO TAL COMO ACIDO ASCORBICO, CITRICO, MALICO, TARTARICO, ENTRE OTROS; c) EVENTULAMENTE COADYUVANTES COMO CLORURO DE BENZALCONIO Y/O FORMADORES DE COMPLEJOS Y d) COMO DISOLVENTES AGUA O ETANOL O UNA MEZCLA DE ESTOS. ESTA FORMULACION TIENE UN VALOR pH DE 2,5 A 6,5 Y ES UTIL PARA EL TRATAMIENTO DE ENFERMEDADES DE LAS VIAS RESPIRATORIAS COMO ASMA, ENFERMEDADES PULMONARES OBSTRUCTIVAS. TAMBIEN SE REFIERE A UN KIT DE INHALACION QUE COMPRENDE LA FORMULACION Y UN INHALADOR PARA LA NEBULIZACION (RESPIMAT)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004024452A DE102004024452A1 (de) | 2004-05-14 | 2004-05-14 | Aerosolformulierung für die Inhalation von Betaagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20060311A1 true PE20060311A1 (es) | 2006-05-08 |
Family
ID=34979667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005000529A PE20060311A1 (es) | 2004-05-14 | 2005-05-12 | Formulacion en aerosol para la inhalacion de beta-agonistas |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP1809293B1 (es) |
| JP (1) | JP4620730B2 (es) |
| KR (1) | KR101288791B1 (es) |
| CN (1) | CN101056640A (es) |
| AR (1) | AR049096A1 (es) |
| AU (1) | AU2005244414B2 (es) |
| BR (1) | BRPI0511135B8 (es) |
| CA (1) | CA2564379C (es) |
| DE (1) | DE102004024452A1 (es) |
| DK (1) | DK1809293T3 (es) |
| EA (1) | EA012583B1 (es) |
| EC (1) | ECSP067004A (es) |
| ES (1) | ES2575925T3 (es) |
| HU (1) | HUE027780T2 (es) |
| IL (1) | IL179218A (es) |
| MX (1) | MXPA06013216A (es) |
| MY (1) | MY148403A (es) |
| NO (1) | NO20065030L (es) |
| PE (1) | PE20060311A1 (es) |
| PL (1) | PL1809293T3 (es) |
| SG (1) | SG152265A1 (es) |
| TW (1) | TWI356703B (es) |
| UA (1) | UA87312C2 (es) |
| UY (1) | UY28891A1 (es) |
| WO (1) | WO2005110421A2 (es) |
| ZA (1) | ZA200607462B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7056916B2 (en) | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| US7220742B2 (en) | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| JP5270343B2 (ja) | 2005-08-15 | 2013-08-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ベータミメティックスの製造方法 |
| JP2009514933A (ja) * | 2005-11-09 | 2009-04-09 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 吸入用エアロゾル製剤 |
| UY30543A1 (es) * | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de beta- agonistas |
| CA2738617A1 (en) * | 2008-11-21 | 2011-05-27 | Boehringer Ingelheim International Gmbh | Aerosol formulation for the inhalation of beta agonists |
| CA2738616A1 (en) * | 2008-11-21 | 2010-05-27 | Boehringer Ingelheim International Gmbh | Aerosol formulation for the inhalation of beta agonists |
| EP2906218B1 (en) | 2012-10-09 | 2016-12-14 | Boehringer Ingelheim International GmbH | Beta-2-adrenoceptor agonist for the treatment of cough |
| JP2019536812A (ja) | 2016-12-12 | 2019-12-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | オロダテロールとの同時投与による間質性肺疾患の処置方法に使用するためのニンテダニブ |
| EP4069669A1 (en) * | 2019-12-05 | 2022-10-12 | Syngenta Crop Protection AG | One step process for the preparation of phenyl ethyl amine derivatives |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3134590A1 (de) * | 1981-09-01 | 1983-03-10 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue benzo-heterocyclen |
| US4460581A (en) * | 1982-10-12 | 1984-07-17 | Boehringer Ingelheim Kg | (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones |
| JPH0637388B2 (ja) * | 1986-02-17 | 1994-05-18 | 千寿製薬株式会社 | 水性液剤 |
| GB9405019D0 (en) * | 1994-03-15 | 1994-04-27 | Smithkline Beecham Plc | Novel compounds |
| DE10253282A1 (de) * | 2002-11-15 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung |
| PL1781298T4 (pl) * | 2004-04-22 | 2017-07-31 | Boehringer Ingelheim International Gmbh | Kombinacje leków zawierające benzoksazynę do leczenia chorób dróg oddechowych |
| DE102004019539A1 (de) * | 2004-04-22 | 2005-11-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von Atemwegserkrankungen |
| DE102004024451A1 (de) * | 2004-05-14 | 2005-12-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten |
| DE102004024454A1 (de) * | 2004-05-14 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
-
2004
- 2004-05-14 DE DE102004024452A patent/DE102004024452A1/de not_active Withdrawn
-
2005
- 2005-05-10 ES ES05747843.0T patent/ES2575925T3/es not_active Expired - Lifetime
- 2005-05-10 HU HUE05747843A patent/HUE027780T2/en unknown
- 2005-05-10 UA UAA200612949A patent/UA87312C2/ru unknown
- 2005-05-10 KR KR1020067026225A patent/KR101288791B1/ko not_active Expired - Lifetime
- 2005-05-10 DK DK05747843.0T patent/DK1809293T3/en active
- 2005-05-10 EP EP05747843.0A patent/EP1809293B1/de not_active Expired - Lifetime
- 2005-05-10 AU AU2005244414A patent/AU2005244414B2/en not_active Expired
- 2005-05-10 CN CNA2005800154865A patent/CN101056640A/zh active Pending
- 2005-05-10 WO PCT/EP2005/005028 patent/WO2005110421A2/de not_active Ceased
- 2005-05-10 SG SG200902777-2A patent/SG152265A1/en unknown
- 2005-05-10 CA CA2564379A patent/CA2564379C/en not_active Expired - Lifetime
- 2005-05-10 MX MXPA06013216A patent/MXPA06013216A/es active IP Right Grant
- 2005-05-10 BR BRPI0511135A patent/BRPI0511135B8/pt active IP Right Grant
- 2005-05-10 PL PL05747843.0T patent/PL1809293T3/pl unknown
- 2005-05-10 EA EA200602017A patent/EA012583B1/ru not_active IP Right Cessation
- 2005-05-10 JP JP2007512068A patent/JP4620730B2/ja not_active Expired - Lifetime
- 2005-05-11 UY UY28891A patent/UY28891A1/es not_active Application Discontinuation
- 2005-05-12 PE PE2005000529A patent/PE20060311A1/es not_active Application Discontinuation
- 2005-05-12 MY MYPI20052158A patent/MY148403A/en unknown
- 2005-05-13 TW TW094115491A patent/TWI356703B/zh not_active IP Right Cessation
- 2005-05-13 AR ARP050101959A patent/AR049096A1/es unknown
-
2006
- 2006-09-06 ZA ZA200607462A patent/ZA200607462B/en unknown
- 2006-11-02 NO NO20065030A patent/NO20065030L/no not_active Application Discontinuation
- 2006-11-13 EC EC2006007004A patent/ECSP067004A/es unknown
- 2006-11-13 IL IL179218A patent/IL179218A/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2399179T3 (es) | Tratamiento de enfermedad respiratoria | |
| PE20081319A1 (es) | Formulacion de aerosol para la inhalacion de agonistas beta | |
| PE20060311A1 (es) | Formulacion en aerosol para la inhalacion de beta-agonistas | |
| EA025158B1 (ru) | Гетероциклические соединения, лекарственные средства, содержащие указанные соединения, их применение и способы их получения | |
| MEP51008A (en) | Aerosol formulation for inhalation, containing an anticholinergic agent | |
| US20110135582A1 (en) | Combination of medicaments for the treatment of respiratory diseases | |
| ES2380370T3 (es) | Combinaciones farmacológicas que contienen benzoxazina para el tratamiento de enfermedades de las vías respiratorias | |
| ES2668364T3 (es) | Formulación en aerosol para la inhalación de beta-agonistas | |
| JP2007533683A5 (es) | ||
| NO20054767L (no) | Sammensetninger omfattende apomorfin for inhalering i lunge | |
| US20100040559A1 (en) | Use of a Pharmaceutical Composition Comprising an Anticholinergic for Killing Microorganisms and for Treating Respiratory Tract Infections | |
| PE20040326A1 (es) | Medicamento que contiene esteroides y un nuevo anticolinergico | |
| EA200401305A1 (ru) | Аэрозольная композиция для ингаляции, содержащая соль тиотропия | |
| PE20080425A1 (es) | Formulacion aerosol para la inhalacion de beta-agonistas | |
| JP2009537585A (ja) | 呼吸器疾患の治療のための新規医薬組成物 | |
| KR20080024532A (ko) | 신규한 티오트로퓸 염의 제조방법, 신규한 티오트로퓸 염및 이의 약제학적 조성물 | |
| AR038764A1 (es) | Formulacion de una solucion de inhalacion con una sal de tiotropio | |
| ES2442343T3 (es) | Compuestos de sulfonamida para el tratamiento de trastornos respiratorios | |
| JP2011502967A (ja) | β模倣薬の結晶性水和物及びその薬剤としての使用 | |
| JP2009514933A (ja) | 吸入用エアロゾル製剤 | |
| US20110319402A1 (en) | Aerosol formulation for the inhalation of beta agonists | |
| CA2650813A1 (en) | New long-acting drug combinations for the treatment of respiratory diseases | |
| US20100015061A1 (en) | Pharmaceutical Compositions Based on Anticholinergics and Andolast | |
| PE20040327A1 (es) | Medicamento que contiene betamimeticos y un nuevo anticolinergico | |
| US20050042176A1 (en) | Medicaments for inhalation comprising a novel anticholinergic and a steroid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |